Stocks / NASDAQ / Indivior PLC

Indivior PLC

Our Opinion

Indivior PLC is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they exploit animals for product testing.

“The agreement with C4X includes lead candidate C4X3256, a novel, first-in-class, oral, small molecule that has demonstrated preclinical efficacy and tolerability in animal models. The collaboration also includes a library of additional OX1 compounds in the same chemical family.” Read the following article

Company Description

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Company Website: